Clinical Trials Browser

Phase 2 × Multiple Myeloma × Leflunomide × Clear all

NCT04508790 2026-05-29

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

Phase 2 Recruiting

Multiple Myeloma